ANAMAR AB has a total of 54 patent applications. Its first patent ever was published in 2005. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and United Kingdom. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are ONCOARENDI THERAPEUTICS SP Z O O, NEUROTUNE AG and PHARMAGENE LAB LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 8 | |
#3 | United Kingdom | 6 | |
#4 | United States | 5 | |
#5 | Australia | 4 | |
#6 | New Zealand | 3 | |
#7 | Brazil | 2 | |
#8 | Canada | 2 | |
#9 | China | 2 | |
#10 | Israel | 2 | |
#11 | Mexico | 2 | |
#12 | Hong Kong | 1 | |
#13 | Hungary | 1 | |
#14 | India | 1 | |
#15 | Japan | 1 | |
#16 | Republic of Korea | 1 | |
#17 | Serbia | 1 | |
#18 | Russian Federation | 1 | |
#19 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement | |
#4 | Machines | |
#5 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Analysing materials | |
#5 | Acyclic or carbocyclic compounds | |
#6 | Unspecified technologies | |
#7 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Seifert Elisabeth | 16 |
#2 | Boman Arne | 15 |
#3 | Lek Per | 14 |
#4 | Pettersson Lars | 12 |
#5 | Lundberg Lennart | 9 |
#6 | Flood Christofer | 9 |
#7 | Palmqvist Niklas | 9 |
#8 | Wenglen Christina | 7 |
#9 | Heinegaard Dick | 5 |
#10 | Lundstedt Torbjorn | 5 |
Publication | Filing date | Title |
---|---|---|
EP3753924A1 | New tricyclic 5-ht2 antagonists | |
WO2016030445A1 | Aminoguanidines of formula (i) for use in the treatment of fibrosis | |
GB201511017D0 | Method of treatment | |
EP3109237A1 | Novel 5-ht2 antagonists | |
GB201415331D0 | Method of treatment | |
WO2011123044A1 | Method to detect tissue degradation leading to inflammation | |
NZ598124A | Compounds for treatment of inflammation | |
GB201010671D0 | Compounds for treatment of inflammation | |
GB201005495D0 | Compounds for treatment of inflammation | |
EP2411812A1 | Metabolic profiles | |
EP1766411A2 | Method for determining a tissue degradation process by detection of comp neoepitopes |